Nike's China Recovery Remains Elusive Amid Weak Demand and Competition

What happened

Nike's Greater China business continues to struggle, with weak demand, rising local competition, and elevated inventory levels clouding near-term recovery prospects. The company is actively liquidating inventory via increased markdowns, which pressures margins and digital sell-through. North America tariffs added ~270 bps of gross margin headwind in Q3 FY26, offsetting pricing benefits. Management expects negative impacts from China throughout fiscal 2027, while key competitors like adidas and Anta gain share. The multi-quarter reset timeline keeps earnings recovery at risk, reinforcing a cautious outlook.

Implication

NIKE's turnaround is extended into FY27, with China and tariffs as dual headwinds. The stock at ~$42 appears cheap on book value but earnings power is compressed. Investors should monitor quarterly disclosures for reduced markdown language and China digital inflection before adding positions. Without these signals, the risk of further estimate cuts outweighs potential upside.

Thesis delta

The Zacks article reinforces the DeepValue report's bearish thesis by highlighting persistent China weakness and competitive pressure. No shift in call; the thesis remains that inventory liquidation and tariff headwinds will cap near-term earnings recovery.